Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: Disseminated disease of donor origin demonstrated by fluorescence in situ hybridization

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 8, 1998, Pages 708-714

  Lones, Mark A ^a   Lopez Terrada, Dolores ^b   Shintaku, I Peter ^c,d   Rosenthal, Joseph ^e,f   Said, Jonathan W ^c,d  

^a ST JOSEPH HOSPITAL   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPSY; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CHILD; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOBLASTIC LYMPHADENOPATHY; POSTOPERATIVE COMPLICATION; VIRUS DETECTION;

BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MALE; RNA, VIRAL; TISSUE DONORS; VIRAL MATRIX PROTEINS; X CHROMOSOME; Y CHROMOSOME;

EID: 0031926805     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc. 1991;23:1101-1103.
2. Seiden MV, Sklar J. Molecular genetic analysis of post-transplant lymphoproliferative disorders. Hematol Oncol Clin North Am. 1993;7:447-465.
3. Swerdlow SH. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology. 1992;20:373-385.
4. Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 1993;99:265-276.
5. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981;41: 4262-4279.
6. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood. 1988;71:1234-1243.
7. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988;133:173-192.
8. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Probl Surg. 1988;25:365-472.
9. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet. 1984;1:583-587.
10. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552-565.
11. Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72:520-529.
12. Skinner JC, Gilbert EF, Hong R, et al. B cell lymphoproliferative disorders following T cell depleted allogeneic bone marrow transplantation. Am J Pediatr Hematol Oncol. 1988;10:112-119.
13. Davey DD, Kamat D, Laszewski M, et al. Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis. Mod Pathol. 1989;2:27-34.
14. d'Amore ESG, Manivel C, Gajl-Peczalska KJ, et al. B-Cell lymphoproliferative disorders after bone marrow transplant: an analysis of ten cases with emphasis on Epstein-Barr virus detection by in situ hybridization. Cancer. 1991;68: 1285-1295.
15. Simon M, Bartram CR, Friedrich W, et al. Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients: a clinical, immunobiological and pathological study. Virchows Arch B Cell Pathol. 1991;60:307-319.
16. Orazi A, Hromas RA, Neiman RS, et al. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol. 1997;107:419-429.
17. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I. Post-transplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol. 1995;103:748-755.
18. Penn I. Host origin of lymphomas in organ transplant recipients. Transplantation. 1979;27:214.
19. Penn I. Lymphomas complicating organ transplantation. Transplant Proc. 1983;15:2790-2797.
20. Chadburn A, Cesarman E, Michler RE, Knowles DM. Post-transplantation lymphoproliferative disorders (PT-LPDs) arising in solid organ transplant recipients are of recipient origin. Mod Pathol. 1995;8:107A.
21. Gossett TC, Gale RP, Fleischman H, et al. Immunoblastic sarcoma in donor cells after bone-marrow transplantation. N Engl J Med. 1979;300:904-907.
22. Martin PJ, Shulman HM, Schubach WH, et al. Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. Ann Intern Med. 1984;101:310-315.
23. Papadopoulos EB, Ladanyi M, Emanuel D, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med. 1994;330:1185-1191.
24. Said JW, Pinkus GS, Lones MA, Preston MA, Shintaku IP. Expression of bcl-2 oncogene protein in malignant lymphomas, including Hodgkin's disease and non-Hodgkin's lymphomas of T-cell phenotype. Appl Immunohistochem. 1993;1:108-114.
25. Pinkus GS, Lones MA, Shintaku IP, Said IW. Immunohistochemical detection of Epstein-Barr virus encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease. Mod Pathol. 1994;7:454-461.
26. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255.
27. Said JW, Barrera R, Shintaku IP, Nakamura H, Koeffler HP. Immunohistochemical analysis of p53 expression in malignant lymphomas. Am J Pathol. 1992; 141:1343-1348.
28. Lones MA, Lopez-Terrada D, Weiss LM, Shintaku IP, Said JW. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med. 1997;121: 701-706.
29. Collins N, Kernan N, Bleau S, O'Reilly R. T-cell depletion of allogeneic human bone marrow grafts by soybean lectin agglutination and either sheep red blood cell rosetting or adherence on the CD5/CD8 Cellector TM. In: Gee A, ed. Bone Marrow Processing and Purging: A Practical Guide. Boca Raton Fla: CRC Press; 1991:201.
30. Della Croce Dr, Imam A, Brynes RK, Nathwani BN, Taylor CR. Anti-BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues. Hematol Oncol. 1991;9:103-114.
31. Cohen PL, Butmarc J, Kadin ME. Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin. Am J Clin Pathol. 1995;104:50-53.
32. Rooney CM, Smith CA, Ng CYC, et al. Use of gene-modified virus specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 1995;345:9-13.
33. Alshak N, Jiminez AM, Gedebou M, et al. Epstein-Barr virus infection in liver transplantation patients: correlation of histopathology and semiquantitative Epstein-Barr virus-DNA recovery using polymerase chain reaction. Hum Pathol. 1993;24:1306-1312.
34. Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Hum Pathol. 1997;28:533-539.
35. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985;43: 831-840.
36. Schubach WH, Hackman R, Nieman PE, Miller G, Thomas ED. A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood. 1982;60:180-187.